Molecular Partners Ag (MOLN) Operating Margin (2022 - 2025)

Molecular Partners Ag (MOLN) posted quarterly Operating Margin of 100000.0% for Q2 2025, up 102994513217.0% year-on-year from N/an in Q2 2024, and up 99.99% on a QoQ basis from 1030045132.17% in Q2 2024.

Molecular Partners Ag (MOLN) Operating Margin (2022 - 2025) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Operating Margin for 4 consecutive years, with 100000.0% the latest figure, recorded in Q2 2025.

  • Quarterly Operating Margin rose 102994513217.0% year-over-year to 100000.0% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 1.8% (changed N/A YoY) and the FY2025 annual result came in at 100041308.09%, down 10004008375.0% from the prior year.
  • Operating Margin climbed to 100000.0% in Q2 2025 per MOLN's latest filing, from 1030045132.17% in the prior quarter.
  • Over the last five years, Operating Margin for MOLN reached as high as 1297.44% in Q2 2022 and fell as low as 1030045132.17% in Q2 2024.
  • A 4-year average of 257536915.49% and a median of 51913.61% in 2023 frame the typical range for Operating Margin.
  • Annual changes were most pronounced in 2024 — Operating Margin sank 2000000000 bps — and 2025, when it soared 2000000000 bps.
  • Year by year, Operating Margin stood at 1297.44% in 2022, then plunged by 395 bps to 3827.23% in 2023, then tumbled by 26913501 bps to 1030045132.17% in 2024, then jumped by 100 bps to 100000.0% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods registered 100000.0%, 1030045132.17%, and 3827.23% for Q2 2025, Q2 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -100,000.00%
Jun 30, 2024 -1,030,045,132.17%
Jun 30, 2023 -3,827.23%
Jun 30, 2022 1,297.44%